FDA Drug recall D-0104-2025
Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478
- FDA Drug
- Class II
- ongoing
- Published 2024-12-11
On 2024-12-11 the FDA classified a Class II recall of Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478 by Avkare, citing labeling: Label Mix-Up.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0104-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2024-10-18 |
| Published | 2024-12-11 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Avkare |
| Distribution | US |
Product
Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-902-28
Reason
Labeling: Label Mix-Up
Identifiers
| ndc | 42291-901-28 |
|---|---|
| ndc | 42291-902-28 |
| ndc | 42291-903-28 |
| ndc | 42291-904-28 |
| code_info | Lot #: 100049501, Exp. Date 07/31/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0104-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.